Close
ACHEMA MIDDLE EAST 2026

FDA Rebukes Althera On Cholesterol Medication Assertions

Althera Pharmaceuticals, a producer of cardiovascular drugs, is being investigated by the FDA for its cholesterol oral delivery medicine, Roszet. The FDA's Office of...

Rejected By The FDA, NICE Endorses The Anaemia Drug Evrenzo

Despite a high-profile FDA denial, FibroGen and its collaborators have been able to expand into new markets outside of the United States with Evrenzo,...

Bluebird Gene Therapy Given FDA Nod Despite Safety Issues

Bluebird bio has persuaded an expert committee that the benefits of its gene therapy possibility, eli-cel, exceed the risks, at least in certain patients,...

Bispecific Blood Cancer Drug By Roche Globally Approved

Roche is exploring new products to refill its blood cancer armoury after Rituxan's patent expiration. Swiss pharma is launching a novel bispecific lymphoma medicine...

USFDA Warns of Heart Irritation After Novavax COVID Vaccine

Even though the company's analysis found it could reduce the likelihood of mild-to-severe disease, the US Food and Drug Administration has expressed concern about...

FDA Grants Novartis Cell Therapy For Follicular Lymphoma

The US Food and Drug Administration (FDA) has granted Novartis expedited approval for its CAR-T cell therapy Kymriah (tisagenlecleucel) to treat people with relapsed...

EMA guidance supports development of new antibiotics

As part of its efforts to support a global approach to the development of new antimicrobial medicines, EMA has published the final revised guideline...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...